See your potential weight loss Determine how much weight you may lose with Veronvy®

Average weight loss with Veronvy® in a medical study:

In a 12-week medical study of 1,961 adults* living with obesity or overweight with a related medical problem along with reduced-calorie diet and increased physical activity:

On average lost  ~35 LBS
People taking placebo (not on medicine) lost an average of ~2.5% body weight (or about 6 lb)
Average starting weight in both groups: ~232 lb
 

In addition to a reduced-calorie diet and increased physical activity, people in this study taking Veronvy® lost more weight vs placebo.

  • of adults taking Veronvy® lost 5% or more weight, compared to 31% taking placebo

  • of adults taking Veronvy® lost 10% or more weight, compared to 12% taking placebo

  • of adults taking Veronvy® lost 15% or more weight, compared to 5% taking placebo

In the same study, some people lost even more weight

30% of people taking Veronvy® lost 20% or more weight, compared to 2% of people taking placebo, in a supportive measure. This result was not the primary goal of the medical study and should be considered as additional information.

Individual results may vary.

*Results are from a 68-week medical study of adults with obesity (BMI ≥30) and adults with overweight (BMI ≥27) who also had weight-related medical problems including high blood pressure or high cholesterol. People with type 2 diabetes were excluded. Both groups received instruction for a reduced-calorie diet and increased physical activity. During the trial, 17% of participants taking WW&Napharm® discontinued treatment compared with 22% taking placebo.

 
See the potential weight loss you could experience with Veronvy® along with a reduced-calorie diet and increased physical activity.

Discover your potential weight loss with Veronvy®

 

Formula Framework for Maximum Weight Loss

Max Weight Loss=(Wi×M)×E×D\text{Max Weight Loss} = (W_i \times M) \times E \times D

Where:

  • WiW_i = Initial body weight in kilograms (kg)
  • MM = Metabolic boost factor (this could be a fixed value based on clinical data or an average derived from user data, e.g., 0.05 for 5% weight loss potential per month)
  • EE = Effectiveness coefficient of the drops (this could be derived from clinical trials, e.g., 1.2 if the drops increase weight loss by 20%)
  • DD = Duration in months (e.g., 2 months for a short-term goal)

Example Calculation

Assume:

  • Initial body weight WiW_i = 100 kg
  • Metabolic boost factor MM = 0.05 (5% weight loss potential per month)
  • Effectiveness coefficient EE = 1.2
  • Duration DD = 2 months

Max Weight Loss=(100×0.05)×1.2×2\text{Max Weight Loss} = (100 \times 0.05) \times 1.2 \times 2 Max Weight Loss=5×1.2×2\text{Max Weight Loss} = 5 \times 1.2 \times 2 Max Weight Loss=12 kg\text{Max Weight Loss} = 12 \text{ kg}

This simplified formula suggests that a person starting at 100 kg could potentially lose up to 12 kg in 2 months with the drops, assuming the factors remain constant.

Considerations

  • Initial Body Weight (Wi): The heavier the initial body weight, the more significant the potential weight loss.
  • Metabolic Boost Factor (M): This factor could vary based on individual metabolic rates and how the drops influence metabolism.
  • Effectiveness Coefficient (E): Based on clinical effectiveness, reflecting how much more effective the drops are compared to other methods.
  • Duration (D): Longer duration typically allows for more significant weight loss, but the rate may decrease over time as the body adjusts.

Limitations

  • Individual Variability: Results can vary widely based on individual differences in metabolism, adherence to dosage, and lifestyle factors.
  • Lifestyle Factors: Diet, exercise, and other lifestyle factors significantly influence weight loss outcomes.
  • Medical Conditions: Underlying medical conditions can affect weight loss and should be considered.